|The TGF beta 1 tgfb1 (Catalog #MBS535978) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s TGF beta 1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Flow Cytometry (FC/FACS), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Western Blot (WB), Neutralization.
FC: 2.5 ug/10^6 cells
IHC: 5-15 ug/ml
ICC: 5-15 ug/ml
WB: 1 ug/ml. Researchers should empirically determine the suitability of the TGF beta 1 tgfb1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TGF beta 1 tgfb1 product has the following accession number(s) (GI #63025222) (NCBI Accession #NP_000651.3) (Uniprot Accession #P01137). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Affinity purified Goat polyclonal TGF beta 1 antibody.
Biological Significance: Transforming growth factor (sometimes referred to as Tumor growth factor, or TGF) is used to describe two classes of polypeptide growth factors, TGF alpha and TGFBeta.
Bioactivity: ND50 is typically 15-30 ug/ml in the presence of 125 ng/ml of recombinant human LAP TGF beta 1 and 0.25 ng/ml TGF beta 1.
Endotoxin Levels: <10 ng per 1 mg of the antibody as determined by the LAL method. Immunogen: TGF beta 1 antibody was raised in goat using CHO cell-derived recombinant human LAP (TGF-beta1) as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing TGF beta 1 are readily searchable from our website. Different antibodies against the same target such as TGF beta 1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Asthma, Diabetic Nephropathies, Fibrosis, Hypersensitivity, Hypertension, Liver Cirrhosis, Lung Diseases, Neoplasm Metastasis, Proteinuria, Pulmonary Fibrosis are some of the diseases may be linked to TGF beta 1 antibody. TGF beta 1 also interacts with the following gene(s): ACVRL1, APP, DCN, LTBP1, LTBP4, SMAD2, SMAD3, SMAD7, TGFBR1, TGFBR2. The following patways have been known to be associated with this gene. Blood, Bone, Bone Marrow, Connective Tissue, Heart, Kidney, Liver, Lung, Muscle, Skin tissues are correlated with this protein.